The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
Abstract
OBJECTIVE—The most promising β-cell replacement therapy for children with type 1 diabetes is a closed-loop artificial pancreas incorporating continuous glucose sensors and insulin pumps. The Medtronic MiniMed external physiological insulin delivery (ePID) system combines an external pump and sensor with a variable insulin infusion rate algorithm designed to emulate the physiological characteristics of the β-cell. However, delays in insulin absorption associated with the subcutaneous route of delivery inevitably lead to large postprandial glucose excursions. RESEARCH DESIGN AND METHODS—We studied the feasibility of the Medtronic ePID system in youth with type 1 diabetes and hypothesized that small manual premeal “priming” boluses would reduce postprandial excursions during closed-loop control. Seventeen adolescents (aged 15.9 ± 1.6 years; A1C 7.1 ± 0.8%) underwent 34 h of closed-loop control; 8 with full closed-loop (FCL) control and 9 with hybrid closed-loop (HCL) control (premeal priming bolus). RESULTS—Mean glucose levels were 135 ± 45 mg/dl in the HCL group versus 141 ± 55 mg/dl in the FCL group (P = 0.09); daytime glucose levels averaged 149 ± 47 mg/dl in the HCL group versus 159 ± 59 mg/dl in the FCL group (P = 0.03). Peak postprandial glucose levels averaged 194 ± 47 mg/dl in the HCL group versus 226 ± 51 mg/dl in the FCL group (P = 0.04). Nighttime control was similar in both groups (111 ± 27 vs. 112 ± 28 mg/dl). CONCLUSIONS—Closed-loop glucose control using an external sensor and insulin pump provides a means to achieve near-normal glucose concentrations in youth with type 1 diabetes during the overnight period. The addition of small manual priming bolus doses of insulin, given 15 min before meals, improves postprandial glycemic excursions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Steil, G. M., Rebrin, K., Darwin, C., Hariri, F., & Saad, M. F. (2006) · Diabetes · doi:10.2337/db06-0419 · Cited by 473
Self-citationContinuous glucose monitoring and closed‐loop systems
Hovorka, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01672.x · Cited by 443
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Closed-loop insulin delivery—the path to physiological glucose control
Steil, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.011 · Cited by 313
Self-citationInsulin Resistance of Puberty: a Defect Restricted to Peripheral Glucose Metabolism*
AMIEL, S. A., CAPRIO, S., SHERWIN, R. S., PLEWE, G., HAYMOND, M. W., & TAMBORLANE, W. V. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-277 · Cited by 299
Self-citationAhrén, B., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1030 · Cited by 292
Bequette, B. W. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.28 · Cited by 270
Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System
Weinstein, R. L., Schwartz, S. L., Brazg, R. L., Bugler, J. R., Peyser, T. A., & McGarraugh, G. V. (2007) · Diabetes Care · doi:10.2337/dc06-1602 · Cited by 228
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus
Rother, K. I., & Harlan, D. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423235 · Cited by 220
Ramsey, B. W., & Boat, T. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70301-9 · Cited by 200
Garg, S. K., Schwartz, S., & Edelman, S. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.734 · Cited by 161
Bulsara, M. K., Holman, C. D. J., Davis, E. A., & Jones, T. W. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2293 · Cited by 154
Closing the Loop: The Adicol Experience
Hovorka, R., Chassin, L. J., Wilinska, M. E., Canonico, V., Akwi, J. A., Federici, M. O., Massi‐Benedetti, M., Hutzli, I., Zaugg, C., Kaufmann, H., et al. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504774197990 · Cited by 153
Wilson, D. M., Beck, R. W., Tamborlane, W. V., Dontchev, M., Kollman, C., Chase, P., Fox, L. A., Ruedy, K. J., Tsalikian, E., WEINZIMER, S. A., et al. (2006) · Diabetes Care · doi:10.2337/dc06-1407 · Cited by 134
Self-citationEvaluation of Factors Affecting CGMS Calibration
Diabetes Research In Children Network (Direcnet) Study Group (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.318 · Cited by 116
Modeling β -Cell Insulin Secretion - Implications for Closed-Loop Glucose Homeostasis
Steil, G. M., Rebrin, K., Janowski, R., Darwin, C. H., & Saad, M. F. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322640999 · Cited by 88
Self-citationThe Diabetes Research in Children Network (DirecNet) Study Group (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.109 · Cited by 82
Cited by
Point of Care Diagnostics: Status and Future
Gubala, V., Harris, L. F., Ricco, A. J., Tan, M. X., & Williams, D. E. (2012) · Analytical Chemistry · doi:10.1021/ac2030199 · Cited by 1,194
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Artificial Pancreas: Past, Present, Future
Cobelli, C., Renard, E., & Kovatchev, B. (2011) · Diabetes · doi:10.2337/db11-0654 · Cited by 600
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Self-citation
Metadata
- Authors
- Weinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-05-01
- Volume
- 31
- Issue
- 5
- Pages
- 934-939
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2144785271
- Cited by
- 567
- References
- 22
- FWCI
- 28.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.